$NBIO 2 cancer drugs in clinical trials OTCQB Clean Level 2 Unusual trading volume No Dilution No VERT VFIN or VNDM www.nascentbiotech.com/wp-content/uploads/2016/12/NBIO-Investor-Presentation-11.12.2016.pdf